Nizam's Institute of Medical Sciences performs a groundbreaking Transcatheter Mitral Valve Replacement (TMVR) surgery for the ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

According to NIMS hospital authorities, this was for the first time that in its history that the Cardiology team has managed to conduct a TMVR procedure on the patient, who was suffering from severe m ...

Doctors at the Nizam’s Institute of Medical Sciences (NIMS), Hyderabad have successfully treated a 56-year-old man suffering ...

Japanese researchers say they have found a pill that works as well as existing medication to prevent blood clots afte ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

and Transcatheter Mitral Valve Repair (TMVR) have revolutionized the field by offering less invasive alternatives to ...

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...

For this trial, researchers compared its use to warfarin in about 400 patients in Japan who had heart valve replacement surgery. Participants received either edoxaban or warfarin for 12 weeks.

Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.